1st Quarter - Report — ALERE INC. for ALERE INC. (2012)

Firm

ALERE INC.

Client

ALERE INC.

Income

—

Expenses

$153,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA regulation of clinical diagnostic laboratory tests The Generating Antibiotics Incentives Now Act (H.R. 2182, S. 1734) FDA regulation of prescription drugs

Lobbyist	Covered position, as disclosed
SETH M RADUS	—

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 2182 (112th), S. 1734 (112th)

Medicare/Medicaid MMM

Medicare payment for clinical diagnostic laboratory tests Medicare coverage for clinical diagnostic laboratory tests

Lobbyist	Covered position, as disclosed
SETH M RADUS	—

Contacted: Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Development of new and innovative clinical diagnostic laboratory tests.

Lobbyist	Covered position, as disclosed
SETH M RADUS	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.